CYPRESS CAPITAL GROUP Gilead Sciences, Inc. Transaction History

CYPRESS CAPITAL GROUP portfolio value:

$4.55M
portfolio value

CYPRESS CAPITAL GROUP quarter portfolio value change:

-0.19%
quarter

Gilead Sciences, Inc. 13F transactions

Quarter Transaction type Change Relative change Absolute change Change value Avg. price Shares
Q3 2022 share Increase +1.35% 982 shares 51K $61.69 73.77K
Q2 2022 share Increase +11.39% 7.44K shares 615K $61.81 72.79K
Q1 2022 share Increase +23.62% 12.48K shares 46K $59.45 65.34K
Q4 2021 share Increase +21.98% 9.52K shares 812K $73.36 52.86K
Q3 2021 share Decrease -2.18% -964 shares -24K $69.85 43.33K
Q2 2021 share Decrease -0.70% -313 shares 168K $68.17 44.30K
Q1 2021 share Increase +2.18% 951 shares 340K $63.33 44.61K
Q4 2020 share Decrease -4.54% -2.07K shares -347K $56.43 43.66K
Q3 2020 share Decrease -17.35% -9.60K shares -1.36M $60.52 45.73K
Q2 2020 share Increase +16.31% 7.75K shares 701K $72.94 55.34K
Q1 2020 share Increase +8.53% 3.73K shares 708K $70.22 47.58K
Q4 2019 share Decrease -3.37% -1.53K shares -27K $60.43 43.84K
Q3 2019 share Decrease -2.00% -928 shares -252K $58.4 45.37K
Q2 2019 share Increase +3.85% 1.71K shares 229K $61.67 46.30K
Q1 2019 share Decrease -7.02% -3.36K shares -100K $58.79 44.58K
Q4 2018 share Decrease -5.67% -2.88K shares -926K $56.02 47.95K
Q3 2018 share Increase +24.53% 10.01K shares 1.03M $68.57 50.83K
Q2 2018 share Decrease -6.80% -2.98K shares -410K $62.43 40.81K
Q1 2018 share Increase +6.37% 2.62K shares 352K $65.91 43.79K
Q4 2017 share Decrease -2.53% -1.06K shares -473K $62.19 41.17K
Q3 2017 share Increase +1.20% 500 shares 468K $69.84 42.24K
Q2 2017 share Increase +0.06% 25 shares 122K $60.63 41.74K
Q1 2017 share Decrease -1.71% -725 shares -206K $57.72 41.72K
Q4 2016 share Increase +0.70% 296 shares -296K $60.39 42.44K
Q3 2016 share Decrease -11.94% -5.71K shares -658K $66.31 42.14K
Q2 2016 share Decrease -7.85% -4.07K shares -778K $69.49 47.86K
Q1 2016 share Decrease -5.58% -3.06K shares -795K $76.1 51.94K